版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OABCD1234567891011121317161514ONH3COO
2、HCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2O1819ONH3COOHCH3H3PO41 1/2H2O雌甾烷雌甾烷13-CH3雄甾雄甾烷烷10-CH313-CH3孕甾烷孕甾烷10-CH313-CH317-C2H5ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2O用用-表示取代基處于環(huán)平面的上方,用實(shí)線連接;表示取代基處于環(huán)平面的上方,用實(shí)線連接; 用用-表示取代基處于環(huán)下方,用虛線連接。表示取代基處于環(huán)下方,用虛線連接。用用“去甲基去甲基”或或“降降”表示比原母核失去一個(gè)甲基表示比原母核失去一個(gè)甲基或環(huán)縮小一個(gè)碳
3、原子;用或環(huán)縮小一個(gè)碳原子;用“高高”表示環(huán)擴(kuò)大一個(gè)碳原子。表示環(huán)擴(kuò)大一個(gè)碳原子。雙鍵的位次可用阿拉伯?dāng)?shù)字表示,亦可用雙鍵的位次可用阿拉伯?dāng)?shù)字表示,亦可用“”來表來表示。示。123456789101112131415161712345678910111213141516171,41,5(10)ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2O ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OOHHOHOOOHHOOHHOOHO雌二醇脫氫酶雌二醇脫氫酶16-羥化酶16-羥化酶雌二醇雌酮雌三醇ONH3CO
4、OHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2O結(jié)構(gòu)特點(diǎn):結(jié)構(gòu)特點(diǎn): 以雌甾烷為母核以雌甾烷為母核 A環(huán)芳構(gòu)化環(huán)芳構(gòu)化 3,17-二醇二醇HOHHHHCOHH3ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2O 雌二醇肌肉注射給藥起效迅速,但作雌二醇肌肉注射給藥起效迅速,但作用時(shí)間短;在胃腸道及肝臟中迅速失活,用時(shí)間短;在胃腸道及肝臟中迅速失活,因此口服無效。因此口服無效。 對(duì)雌激素的改造,不以增強(qiáng)藥效為目對(duì)雌激素的改造,不以增強(qiáng)藥效為目的。而是:的。而是:延效和口服延效和口服ONH3COOHCH3H3PO41
5、1/2H2OONH3COOHCH3H3PO41 1/2H2OOHOOHOO苯甲酸雌二醇戊酸雌二醇CH3OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2O 雌激素在動(dòng)物體內(nèi)含量較少,天然來雌激素在動(dòng)物體內(nèi)含量較少,天然來源非常有限,從源非常有限,從4-3-酮型甾體轉(zhuǎn)化為芳酮型甾體轉(zhuǎn)化為芳香化香化A環(huán)的合成非常復(fù)雜,所以雌激素來環(huán)的合成非常復(fù)雜,所以雌激素來源困
6、難。源困難。 因此研究雌激素類藥物的另一個(gè)方向就是:因此研究雌激素類藥物的另一個(gè)方向就是:尋找結(jié)構(gòu)簡(jiǎn)單、制備方便的代用品尋找結(jié)構(gòu)簡(jiǎn)單、制備方便的代用品ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2O一些非甾體雌激素結(jié)構(gòu)類型:一些非甾體雌激素結(jié)構(gòu)類型:ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OSchueler(1946年)提出年)提出剛性甾體母核兩端的富電子基團(tuán)(剛性甾體母核兩端的富電子基團(tuán)(OH、=O、NH等)之間的距離應(yīng)在等)之間的距離應(yīng)在1.45nm,分子寬度應(yīng)為分子寬度應(yīng)為0.388nm
7、。0.72nm1.45nmONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OH3CCH3HOOH己烯雌酚己烯雌酚結(jié)構(gòu):結(jié)構(gòu):1.反式有效,平面結(jié)構(gòu),雙鍵氫化無效反式有效,平面結(jié)構(gòu),雙鍵氫化無效 2.酚羥基酸性酚羥基酸性O(shè)NH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OClONCH3CH3ONCH3CH3H3C氯米芬他莫昔芬ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/
8、2H2OHOHHHHCOHH3ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OCH3H3CHOOHONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3CCH3CH3,OHOOHHOOOHOONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H
9、3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2O ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OHOOOO雄素酮睪酮ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2O 睪酮作用時(shí)間短;易在消化道被破壞,睪酮作用時(shí)間短;易在消化道被破壞,因此口服無效;雄性激素作用強(qiáng),蛋白通因此口服無效;雄性激素作用強(qiáng),蛋白通化作用弱,不良反應(yīng)較大?;饔萌?,不良反應(yīng)較大。 針對(duì)這些缺點(diǎn),對(duì)睪酮進(jìn)行一系列的針對(duì)這些缺點(diǎn),對(duì)睪酮進(jìn)行一系列的改造。改造。ONH3COOHCH3H3PO41 1/2H2
10、OONH3COOHCH3H3PO41 1/2H2OOOOOOCH3O丙酸睪酮苯乙酸睪酮ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OOH3CHH3COHHHCH3ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OOHHH3COHHHOONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OOOHOHCH3HOCH3NNH羥甲烯龍司坦唑醇ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OOH3CHH3COHHHCH3
11、ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OOHHH3COHHHOONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2O ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2O
12、OOHOOHCCHCCH炔孕酮炔諾酮ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2O 黃體酮口服易代謝失活,僅能注射給黃體酮口服易代謝失活,僅能注射給藥,因此,獲得可口服的長(zhǎng)效孕激素,就藥,因此,獲得可口服的長(zhǎng)效孕激素,就成了結(jié)構(gòu)改造的主要目的。成了結(jié)構(gòu)改造的主要目的。ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OOCH3OOOCH3CH3OCH3OOOCH3CH3OCH3OOOCH3Cl醋酸甲羥孕酮醋酸甲地孕酮醋酸氯地孕酮ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3
13、PO41 1/2H2OH3COH3CCH3OHHHHONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OOOHCCHONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OOOHNCCCH3ONH3COOHCH3H3PO41 1
14、/2H2OONH3COOHCH3H3PO41 1/2H2O ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OOOHOHOOOOHOHHOOOOHHOOOHCOOHHOO可的松氫化可的松皮質(zhì)酮醛固酮ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OOOHOHCH3OHCH3O氫化可的松的空間位阻ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OOHOOOOHOHO
15、HOOOH潑尼松潑尼松龍ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OOHOHOOOHOHFOOHOOOHOFCH3CH3曲安西龍曲安奈德ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OOHOHOOOHCH3FOHOHOOOHCH3F地塞米松倍他米松ONH3COOHCH3H3PO41 1/2H2OONH3CO
16、OHCH3H3PO41 1/2H2OH3CH3COHOHOOHHHHOCH3OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OH3CH3COHOHOOFHHHOCH3OHCH3ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/
17、2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOH
18、CH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2O1. 磺脲類磺脲類甲磺丁脲甲磺丁脲 D860D860,為第一代磺脲類口為第一代磺脲類口 服降糖藥。服降糖藥。格列苯脲格列苯脲 優(yōu)降糖,優(yōu)降糖,第二代脲類口服降第二代脲類口服降糖藥,糖藥,作用強(qiáng)、持久。作用強(qiáng)、持久。格列齊特格列齊特 達(dá)美康,達(dá)美康,第二代脲類口服降第二代脲類口服降糖藥糖藥 。ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41
19、1/2H2OONH3COOHCH3H3PO41 1/2H2OH3CSNHNHCH3OOOONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OSNHOClH3CONHNHOOOONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2O2. 雙胍類口服降糖藥雙胍類口服降糖藥苯乙雙胍苯乙雙胍 降糖靈,價(jià)格便宜。降糖靈,價(jià)格便宜。
20、二甲雙胍二甲雙胍 降糖片。降糖片。ONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2ONHH2NHNNHNCH3CH3,HClONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2OONH3COOHCH3H3PO41 1/2H2O新型口服降血糖藥物,新型口服降血糖藥物,通過在腸道內(nèi)競(jìng)爭(zhēng)性抑制葡萄糖苷通過在腸道內(nèi)競(jìng)爭(zhēng)性抑制葡萄糖苷酶,降低糖類的吸收,具有降低飯酶,降低糖類的吸收,具有降低飯后高血糖和血漿胰島
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2024上海市高壓供用電合同
- 2024安徽省集體合同條例
- 2024個(gè)人之間借款合同參考范本
- 2024【挖機(jī)轉(zhuǎn)讓協(xié)議合同范本】出租車轉(zhuǎn)讓協(xié)議合同范本
- 2024小區(qū)門衛(wèi)勞動(dòng)合同范本
- 深圳大學(xué)《游戲發(fā)行的商業(yè)實(shí)戰(zhàn)》2021-2022學(xué)年第一學(xué)期期末試卷
- 寫字樓物業(yè)停電應(yīng)急預(yù)案(9篇)
- 關(guān)于新學(xué)期學(xué)習(xí)計(jì)劃范文集合七篇
- 眼鏡店開荒保潔施工合同
- 體育學(xué)校租賃協(xié)議
- (外研版3起)英語(yǔ)四年級(jí)上冊(cè)單詞字帖書寫練習(xí)(手寫體)高清打印版
- 《泡沫滅火系統(tǒng)》課件
- 小學(xué)教學(xué)質(zhì)量提升關(guān)鍵培養(yǎng)學(xué)生良好的學(xué)習(xí)習(xí)慣
- 古代辭章領(lǐng)略古代辭章的風(fēng)華與韻味
- 開放性指骨骨折的護(hù)理查房課件
- Part3-4 Unit5 Ancient Civilization教案-【中職專用】高一英語(yǔ)精研課堂(高教版2021·基礎(chǔ)模塊2)
- 2023年山東濟(jì)南市文化和旅游局所屬事業(yè)單位招聘42人筆試參考題庫(kù)(共500題)答案詳解版
- 開拓海外市場(chǎng):2024年新年計(jì)劃
- 2023-2024學(xué)年遼寧省沈陽(yáng)126中八年級(jí)(上)期中數(shù)學(xué)試卷(含解析)
- 高一選科指導(dǎo)課件
- 生產(chǎn)檢驗(yàn)記錄表
評(píng)論
0/150
提交評(píng)論